Studies examining YKL-40 levels in diabetes and prediabetes have shown that the rise in serum levels of YKL-40 is an indirect response to local inflammatory status, morbid obesity, renal dysfunction [24–26]. This evidence concerns the gene CHI3L1 and morbid obesity.